Journal of Ocular Pharmacology and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q2 | 57.1% | 0.621 | Q2 | 68.9% |
| 2024 | 2.1 | Q2 | 60.2% | 0.597 | Q2 | 68.3% |
| 2023 | 1.9 | Q3 | 36.8% | 0.599 | Q2 | 70.9% |
| 2022 | 2.3 | Q3 | 38.5% | 0.472 | Q2 | 64.6% |
| 2021 | 2.9 | Q3 | 48.4% | 0.580 | Q2 | 71.8% |
| 2020 | — | — | 0.727 | Q2 | 77.2% | |
| 2019 | — | — | 0.650 | Q2 | 74.9% | |
| 2018 | — | — | 0.658 | Q2 | 73.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1080-7683
ISSN
1557-7732
region
Northern America
coverage
1985-2026